Search

The availability of realistic in vitro models is crucial for tissue engineering, disease modeling, and drug screening assays. However, reproducing the complex shapes and intricate structures of naturally occurring tissues or organs in the presence of functional cells remains a challenge. For example, it is still not trivial to obtain cell‐laden tubular structures on a micrometer scale present in the nephrons of the human kidney. Here, a unique hydrogel‐based shrinking approach making use of host–guest interactions to decrease the diameters of the preformed hydrogel tubules seeded with cells is proposed as a tool to overcome the abovementioned challenge. The hydrogels are composed of covalently crosslinked methacrylated hyaluronic acid and methacrylated dextran modified with either cyclodextrin or adamantane groups that can form dynamic bonds. The hydrogels are initially formed in the presence of small‐molecule competitors that block any interpolymer host–guest interactions, and the shrinking process is triggered by the release of these competitor molecules. The high shrinking efficiency with a shrinking factor up to eight times in volume and robust cytocompatibility make the host‐guest‐based shrinking approach an appealing tool to obtain hydrogel tubular in vitro models with the desired dimensions on demand. [ABSTRACT FROM AUTHOR]

To avoid poly(ethylene glycol)-related issues of nanomedicines such as accelerated blood clearance, fully N -2-hydroxypropyl methacrylamide (HPMAm)-based polymeric micelles decorated with biotin for drug delivery were designed. To this end, a biotin-functionalized chain transfer agent (CTA), 4-cyano-4-[(dodecylsulfanylthiocarbonyl)-sulfanyl]pentanoic acid (biotin-CDTPA), was synthesized for reversible addition–fragmentation chain-transfer (RAFT) polymerization. Amphiphilic poly(N -2-hydroxypropyl methacrylamide)- block -poly(N -2-benzoyloxypropyl methacrylamide) (p(HPMAm)-b-p(HPMAm-Bz)) with molecular weights ranging from 8 to 24 kDa were synthesized using CDTPA or biotin-CDTPA as CTA and 2,2′-azobis(2-methylpropionitrile) as initiator. The copolymers self-assembled in aqueous media into micelles with sizes of 40–90 nm which positively correlated to the chain length of the hydrophobic block in the polymers, whereas the critical micelle concentrations decreased with increasing hydrophobic block length. The polymer with a molecular weight of 22.1 kDa was used to prepare paclitaxel-loaded micelles which had sizes between 61 and 70 nm, and a maximum loading capacity of around 10 wt%. A549 lung cancer cells overexpressing the biotin receptor, internalized the biotin-decorated micelles more efficiently than non-targeted micelles, while very low internalization of both types of micelles by HEK293 human embryonic kidney cells lacking the biotin receptor was observed. As a consequence, the paclitaxel-loaded micelles with biotin decoration exhibited stronger cytotoxicity in A549 cells than non-targeted micelles. Overall, a synthetic pathway to obtain actively targeted poly(ethylene glycol)-free micelles fully based on a poly(HPMAm) backbone was established. These polymeric micelles are promising systems for the delivery of hydrophobic anticancer drugs. Unlabelled Image • We developed biotinylated polymeric micelles based on HPMAm for paclitaxel delivery. • Biotinylated p(HPMAm)-b-p(HPMAm-Bz) micelles were efficiently internalized by A549 cells that overexpress biotin receptors. • PEG-free micelles fully based on poly(HPMAm) are attractive systems for the delivery of hydrophobic anticancer drugs. [ABSTRACT FROM AUTHOR]

Thermosensitiveamphiphilic block copolymers self-assemble intomicelles above their lower critical solution temperature in water,however, the micelles generally display mediocre physical stability.To stabilize such micelles and increase their loading capacity forchemotherapeutic drugs, block copolymers with novel aromatic monomerswere synthesized by free radical polymerization of N-(2-benzoyloxypropyl methacrylamide (HPMAm-Bz) or the correspondingnaphthoyl analogue (HPMAm-Nt), with N-(2-hydroxypropyl)methacrylamide monolactate, using a polyethylene glycol based macroinitiator.The critical micelle temperatures and critical micelle concentrationsdecreased with increasing the HPMAm-Bz/Nt content. The micelles of30–50 nm were prepared by heating the polymer aqueous solutionsfrom 0 to 50 °C and were colloidally stable for at least 48 hat pH 7.4 and 37 °C. Paclitaxel and docetaxel encapsulation wasperformed by mixing drug solutions in ethanol with polymer aqueoussolutions and heating from 0 to 50 °C. The micelles had a drugloading capacity up to 34 wt % for docetaxel, which is among the highestloadings reported for polymeric micelles, with loaded micelle sizesranging from 60 to 80 nm. The micelles without aromatic groups almostcompletely released loaded paclitaxel in 10 days, whereas the HPMAm-Bz/Ntcontaining micelles released 50% of the paclitaxel at the same time,which showed a better retention for the drug of the latter micelles. 1H solid-state NMR spectroscopy data are compatible with π–πstacking between aromatic groups. The empty micelles demonstratedgood cytocompatibility, and paclitaxel-loaded micelles showed highcytotoxicity to tumor cells. In conclusion, the π–πstacking effect introduced by aromatic groups increases the stabilityand loading capacity of polymeric micelles. [ABSTRACT FROM AUTHOR]

To study the release of a model protein, bovine serum albumin (BSA), from microspheres of an hydroxylated aliphatic polyester, poly(lactic-co-hydroxymethyl glycolic acid) (PLHMGA). BSA-loaded microspheres were prepared by a double emulsion solvent evaporation method. The effect of copolymer composition and the molecular weight of the copolymer on in vitro release and degradation were studied. The integrity of the released BSA was studied by fluorescence spectroscopy and size exclusion chromatography (SEC). Microspheres prepared from PLHMGA with 50% hydroxymethyl glycolic acid (HMG) showed a burst release followed by a sustained release in 5–10 days. PLHMGA microspheres prepared from a copolymer with 35% and 25% HMG showed a sustained release of BSA up to 80% for 30 and 60 days, respectively. The release of BSA was hardly affected by the molecular weight of the polymer. Fluorescence spectroscopy and SEC showed that the released BSA preserved its structural integrity. Microspheres were fully degradable, and the degradation time increased from ~20 days to 60 days when the HMG content decreased from 50% to 25%. Taking the degradation and release data together, it can be concluded that the release of BSA from PLHMGA microspheres is governed by degradation of the microspheres. [ABSTRACT FROM AUTHOR]

Abstract: This paper presents a novel self-gelling hydrogel potentially suitable for controlled drug delivery and tissue engineering. The macroscopic gels are obtained by mixing dispersions of oppositely charged crosslinked dextran microspheres. These microspheres in turn were prepared by crosslinking of dextran derivatized with hydroxyethyl methacrylate emulsified in an aqueous poly(ethylene glycol) solution. Negatively or positively charged microspheres were obtained by addition of methacrylic acid (MAA) or dimethylaminoethyl methacrylate (DMAEMA) to the polymerization mixture. Rheological analysis showed that instantaneous gelation occurred when equal volumes of oppositely charged microspheres, dispersed in buffer solutions of pH 7, were mixed. The shear modulus of the networks could be tailored from 30 to 6500Pa by varying the water content of the system. Moreover, controlled strain and creep experiments showed that the formed networks were mainly elastic. Importantly for application of these systems, e.g. as controlled matrix of pharmaceutically active proteins, it was demonstrated that the hydrogel system has a reversible yield point, meaning that above a certain applied stress, the system starts to flow, whereas when the stress is removed, gel formation occurred. Further it was shown that the network structure could be broken by either a low pH or a high ionic strength of the medium. This demonstrates that the networks, formed at pH 7 and at low ionic strength, are held together by ionic interactions between the oppositely charged dextran microspheres. This system holds promise as injectable gels that are suitable for drug delivery and tissue engineering applications. [Copyright &y& Elsevier]

The rheology of reversible coordination polymer networks in aqueous solution is studied. The polymers are formed by neodymium(III) ions and bifunctional ligands, consisting of two pyridine-2,6- dicarboxylate groups connected at the 4-positions by an ethylene oxide spacer. Neodymium(III) ions can bind three of these terdendate ligand groups. At high concentrations, the polymer networks yield viscoelastic materials, which can be described with the Maxwell model. The scaling of the elastic modulus, relaxation time, and zero-shear viscosity with concentration are in good agreement with the predictions of Cates' model that describes the dynamics of linear equilibrium polymers. This indicates that the networks have only few cross-links and can be described as linear equilibrium polymers. The gels are also thermo-reversible. At high temperatures, fast relaxation was found, resulting in liquidlike behavior. Upon cooling, the viscoelastic properties returned immediately. From the temperature dependence of the relaxation time, an activation energy of 49 kJ/mol was determined for the breaking and reptation of the polymers. [ABSTRACT FROM AUTHOR]

One of the main challenges in clinical translation of polymeric micelles is retention of the drug in the nanocarrier system upon its systemic administration. Core crosslinking and coupling of the drug to the micellar backbone are common strategies to overcome these issues. In the present study, polymeric micelles were prepared for tumor cell targeting of the kinase inhibitor dactolisib which inhibits both the mammalian Target of Rapamycin (mTOR) kinase and phosphatidylinositol-3-kinase (PI3K). We employed platinum(II)-based linker chemistry to couple dactolisib to the core of poly(ethylene glycol)- b -poly(acrylic acid) (PEG- b -PAA) polymeric micelles. The formed dactolisib-PEG-PAA unimers are amphiphilic and self-assemble in an aqueous milieu into core–shell polymeric micelles. Folate was conjugated onto the surface of the micelles to yield folate-decorated polymeric micelles which can target folate receptor over-expressing tumor cells. Fluorescently labeled polymeric micelles were prepared using a lissamine-platinum complex linked in a similar manner as dactolisib. Dactolisib polymeric micelles showed good colloidal stability in water and released the coupled drug in buffers containing chloride or glutathione. Folate decorated micelles were avidly internalized by folate-receptor-positive KB cells and displayed targeted cellular cytotoxicity at 50–75 nM IC 50. In conclusion, we have prepared a novel type of folate-receptor targeted polymeric micelles in which platinum(II) linker chemistry modulates drug retention and sustained release of the coupled inhibitor dactolisib. [ABSTRACT FROM AUTHOR]

Active self-encapsulation (ASE) is a recently developed post-loading method based on absorption of (positively charged) proteins in microporous PLGA microspheres loaded with negatively charged polysaccharides (trapping agents). The aim of this study was to investigate ASE for simultaneous loading and controlled release of multiple growth factors. For this purpose, vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF) and insulin-like growth factor (IGF) were loaded in microspheres containing high molecular weight dextran sulfate (HDS) as trapping agent; loading was performed in a concentrated growth factor solution of low ionic strength and of pH 5 under conditions at which the proteins are positively charged. Subsequent pore closure was induced by incubation of the growth factor-loaded microspheres at 42.5 °C, i.e. above the T g of (hydrated) PLGA (~30 °C). A 1:1:1 combination of VEGF, FGF and IGF was loaded with high loading (4.3%) and loading efficiency (91%). The in vitro release kinetics and bioactivity of loaded growth factors were studied for 4 weeks using ELISA and an endothelial cell proliferation assay, respectively. While IGF was released quickly, VEGF and FGF were continuously released for 4 weeks in their bioactive form, whereby a growth factor combination had a synergistic angiogenic effect. Therefore, ASE is a suitable method for co-loading growth factors which can provide sustained release profiles of bioactive growth factors, which is attractive for vascularization of biomaterial implants. [ABSTRACT FROM AUTHOR]

The size of polymeric micelles crucially affects their tumor accumulation, penetration and antitumor efficacy. In the present study, micelles were formed based on amphiphilic poly(N -2-hydroxypropyl methacrylamide)- block -poly(N -2-benzoyloxypropyl methacrylamide) (p(HPMAm)-b-p(HPMAm-Bz)) via the solvent extraction method, and factors impacting micelle size were systematically studied, including the molecular weight of the polymers, homopolymer content, and processing methods (i.e., batch process versus continuous microfluidics). The formation of core-shell structured micelles was demonstrated by light scattering, sedimentation velocity and electron microscopy analysis. Micellar size and aggregation number increased with decreasing the molecular weight ratio of the hydrophilic/hydrophobic block. The presence of hydrophobic p(HPMAm-Bz) homopolymer and high copolymer concentration increased micelle size, while the presence of hydrophilic p(HPMAm) homopolymer did not affect micellar size. Regarding processing conditions, it was found that the use of tetrahydrofuran and acetone as solvents for the polymers resulted in larger micelles, likely due to their relatively high water-solvent interaction parameters as compared to other solvents tested, i.e., dimethylformamide, dimethylacetamide, and dimethyl sulfoxide. Among the latter, only dimethylformamide led to micelles with a narrow polydispersity. Addition of dimethylformamide to an aqueous solvent and faster mixing of two solvents using microfluidics favored the formation of smaller micelles. In conclusion, our results show that the size of all-HPMA polymeric micelles can be easily tailored from 40 to 120 nm by varying the formulation properties and processing parameters. [Display omitted] • All-HPMAm based polymeric micelles were fabricated and characterized using various techniques. • Microfluidics produced small p(HPMAm)-b-p(HPMAm-Bz) micelles with controlled features. • Size of p(HPMAm)-b-p(HPMAm-Bz) micelles was tailored for EPR-based delivery by controlling the polymer properties. [ABSTRACT FROM AUTHOR]

Abstract: Chitosan derivatives such as N,N,N-trimethylated chitosan (TMC) are currently being investigated for the delivery of drugs, vaccines and genes. However, the influence of the extent of N-acetylation of these polymers on their enzymatic degradability and biological properties is unknown. In this study, TMCs with a degree of acetylation (DA) ranging from 11 to 55% were synthesized by using a three-step method. First, chitosan was partially re-acetylated using acetic anhydride followed by quantitative dimethylation using formaldehyde and sodium borohydrate. Then, in presence of an excess amount of iodomethane, TMC was synthesized. The TMCs obtained by this method showed neither detectable O-methylation nor loss in acetyl groups (1H NMR) and a slight increase in molecular weight (GPC) with increasing degree of substitution, implying that no chain scission occurred during synthesis. The extent of lysozyme-catalyzed degradation of TMC, and that of its precursors chitosan and dimethyl chitosan, was highly dependent on the DA and polymers with the highest DA showed the largest decrease in molecular weight. On Caco-2 cells, TMCs with a high DA (∼50%), a DQ of around 44% and with or without O-methylated groups, were not able to open tight junctions in the trans-epithelial electrical resistance (TEER) assay, in contrast with TMCs (both O-methylated and O-methyl free; concentration 2.5mg/ml) with a similar DQ but a lower DA which were able to reduce the TEER with 30 and 70%, respectively. Additionally, TMCs with a high DA (∼50%) demonstrated no cell toxicity (MTT, LDH release) up to a concentration of 10mg/ml. [Copyright &y& Elsevier]

Abstract: Our previous studies showed that degradable dextran hydrogels are rapidly formed in situ upon mixing aqueous solutions of dextran vinyl sulfone (dex-VS) conjugates and tetrafunctional mercapto poly(ethylene glycol) (PEG-4-SH) by Michael addition. The hydrogel degradation time and storage modulus could be controlled by the degree of vinyl sulfone substitution (DS) and dextran molecular weight. The degradation time could further be adjusted by the spacer between the thioether and the ester bond of the dex-VS conjugates (ethyl vs. propyl, denoted as dex-Et-VS and dex-Pr-VS, respectively). In this paper, the release of three model proteins, i.e. immunoglobulin G (d h =10.7 nm, IgG), bovine serum albumin (BSA, d h =7.2 nm) and lysozyme (d h =4.1 nm), as well as basic fibroblast growth factor (bFGF) from these in situ forming dextran hydrogels is studied. Proteins could be easily loaded into the hydrogels by mixing protein containing solutions of dex-VS and PEG-4-SH. The release of IgG from dex-Et-VS hydrogels followed biphasic release kinetics, with a slow, close to first order release for the first 9 days followed by an accelerated release and over 80% of IgG was released in 12 to 25 days. Interestingly, the release of IgG from dex-Pr-VS hydrogels followed close to zero order kinetics, wherein approximately 95% was released in 21 days. The release of BSA from dex-Pr-VS hydrogels followed biphasic kinetics, with almost first order release followed by close to zero order release. Approximately 75% of the entrapped BSA could be released from dex-Pr-VS hydrogels in 16 days. Dex-Pr-VS hydrogels released 40% of lysozyme in 14 days, with full preservation of the enzymatic activity of the released lysozyme, as determined by bacteria lysis experiments. The release of basic fibroblast growth factor (bFGF) from dex-Pr-VS hydrogels showed first order kinetics, with quantitative release in 28 days. These results show that the in situ forming degradable dextran hydrogels can be used for the controlled release of proteins. [Copyright &y& Elsevier]

In this study the use of dynamic mechanical analysis (DMA) for the mechanical characterisation of pharmaceutical hydrogels was evaluated. DMA was used in two different modes, the “controlled force” and the “multi-strain” (MS). The results obtained on dextran methacrylate hydrogels of various compositions were compared to those obtained using an oscillatory shear rheometer. The best agreement was found between the MS-DMA and the rheometer results. The moduli measured in MS-DMA were extrapolated towards zero compression to obtain the modulus of the hydrogels. This procedure resulted in good agreement with the data obtained with the rheometer. Hydrogels were analysed after swelling to equilibrium with both methods, DMA and rheology. A scaling between the elastic modulus (G′) and the equilibrium swollen polymer volume fraction (v2,s) could be found, although the best correlation between G′ and v2,s was obtained with the rheometer. [Copyright &y& Elsevier]

Polymeric micelles are attractive nanocarriers for hydrophobic drug molecules such as the kinase inhibitor dactolisib. Two different poly(ethylene glycol)–poly(acrylic acid) (PEG‐b‐PAA) block‐copolymers are synthesized, PEG(5400)‐b‐PAA(2000) and PEG(10000)‐b‐PAA(3700), respectively. Polymeric micelles are formed by self‐assembly once dactolisib is conjugated via the ethylenediamine platinum(II) linker (Lx) to the PAA block of the block copolymers. Dactolisib micelles with dactolisib loading content of 17% w/w show good colloidal stability and display sustained release of Lx‐dactolisib over 96 h in PBS at 37 °C, while media containing reagents that compete for platinum coordination (e.g., glutathione (GSH) or dithiothreitol (DTT)) effectuate release of the parent inhibitor dactolisib at similar release rates. Dactolisib/lissamine‐loaded micelles are internalized by human breast adenocarcinoma cells (MCF‐7) in a dose and time‐dependent manner as demonstrated by confocal microscopy. Dactolisib‐loaded micelles inhibit the PI3K/mTOR signaling pathway at low concentrations (400 × 10−9m) and exhibit potent cytotoxicity against MCF‐7 cells with IC50 values of 462 ± 46 and 755 ± 75 × 10−9m for micelles with either short or longer PEG‐b‐PAA block lengths. In conclusion, dactolisib loaded PEG‐b‐PAA micelles are successfully prepared and hold potential for nanomedicine‐based tumor delivery of dactolisib. [ABSTRACT FROM AUTHOR]

Abstract The aim of the present study was to develop folic acid (FA) conjugates which can deliver the kinase inhibitor dactolisib to the kidneys via folate receptor-mediated uptake in tubular epithelial cells. Dactolisib is a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) and is considered an attractive agent for treatment of polycystic kidney disease. The ethylenediamine platinum(II) linker, herein called Lx, was employed to couple dactolisib via coordination chemistry to thiol-containing FA-spacer adducts to yield FA-Lx-dactolisib conjugates. The dye lissamine was coupled via similar linker chemistry to folate to yield fluorescent FA-Lx-lissamine conjugates. Three different spacers (PEG 5 -Cys, PEG 27 -Cys or an Asp-Arg-Asp-Asp-Cys peptide spacer) were used to compare the influence of hydrophilicity and charged groups in the spacer on interaction with target cells and in vivo organ distribution of the final conjugates. The purity and identity of the final products were confirmed by UPLC and LC-MS analysis, respectively. FA-Lx-dactolisib conjugates were stable in serum and culture medium, while dactolisib was released from the conjugates in the presence of glutathione. All three type of conjugates were internalized efficiently by HK-2 cells and uptake could be blocked by an excess of folic acid in the medium, demonstrating FR mediated uptake. FA-Lx-dactolisib conjugates showed nanomolar inhibition of the PI3K pathway (Akt phosphorylation) and mTOR pathway (S6 phosphorylation) in cultured kidney epithelial cells (HK-2 cells). After intraperitoneal administration, all three types conjugates accumulated extensively in kidneys of iKsp- Pkd1 del mice with polycystic kidney disease. In conclusion, folate conjugates were successfully prepared by platinum(II) coordination chemistry and accumulated in a target-specific manner in kidney cells and polycystic kidneys. The folate conjugate of dactolisib thus may have potential for targeted therapy of polycystic kidney disease. Graphical abstract Unlabelled Image [ABSTRACT FROM AUTHOR]

One of the complications of bronchotracheal cancer is obstruction of the upper airways. Local tumor resection in combination with an airway stent can suppress intraluminal tumor (re)growth. We have investigated a novel drug-eluting stent coating for local release of the anticancer drug gefitinib. A polyurethane (PU) sandwich construct was prepared by a spray coating method in which gefitinib was embedded between a PU support layer of 200 μm and a PU top layer of 50–200 μm. Gefitinib was either embedded in the construct as small crystals or as gefitinib-loaded poly(lactic- co -glycolic acid) (PLGA) microspheres (MSP). The drug was incorporated in the PU constructs with high recovery (83–93%), and the spray coating procedure did not affect the morphologies of the embedded microspheres as demonstrated by scanning electron microscopy (SEM), confocal laser scanning microscopy and fluorescence microscopy analysis. PU constructs loaded with gefitinib crystals released the drug for 7–21 days and showed diffusion based release kinetics. Importantly, directional release of the drug towards the top layer, which is supposed to face the tumor mass, was controlled by the thicknesses of the PU top layer. PU constructs loaded with gefitinib microspheres released the drug in a sustained manner for > 6 months indicating that drug release from the microspheres became the rate limiting step. In conclusion, the sandwich structure of drug-loaded PLGA microspheres in PU coating is a promising coating for airway stents that release anticancer drugs locally for a prolonged time. [ABSTRACT FROM AUTHOR]

Retinal gene therapy could potentially affect the lives of millions of people suffering from blinding disorders. Yet, one of the major hurdles remains the delivery of therapeutic nucleic acids to the retinal target cells. Due to the different barriers that need to be overcome in case of topical or systemic administration, intravitreal injection is an attractive alternative administration route for large macromolecular therapeutics. Here it is essential that the therapeutics do not aggregate and remain mobile in the vitreous humor in order to reach the retina. In this study, we have evaluated the use of hyaluronic acid (HA) as an electrostatic coating for nonviral polymeric gene nanomedicines, p(CBA-ABOL)/pDNA complexes, to provide them with an anionic hydrophilic surface for improved intravitreal mobility. Uncoated polyplexes had a Z-averaged diameter of 108 nm and a zeta potential of + 29 mV. We evaluated polyplexes coated with HA of different molecular weights (22 kDa, 137 kDa and 2700 kDa) in terms of size, surface charge and complexation efficiency and noticed their zeta potentials became anionic at 4-fold molar excess of HA-monomers compared to cationic monomers, resulting in submicron ternary polyplexes. Next, we used a previously optimized ex vivo model based on excised bovine eyes and fluorescence single particle tracking (fSPT) microscopy to evaluate mobility in intact vitreous humor. It was confirmed that HA-coated polyplexes had good mobility in bovine vitreous humor, similar to polyplexes functionalized with polyethylene glycol (PEG), except for those coated with high molecular weight HA (2700 kDa). However, contrary to PEGylated polyplexes, HA-coated polyplexes were efficiently taken up in vitro in ARPE-19 cells, despite their negative charge, indicating uptake via CD44-receptor mediated endocytosis. Furthermore, the HA-polyplexes were able to induce GFP expression in this in vitro cell line without apparent cytotoxicity, where coating with low molecular weight HA (22 kDa) was shown to induce the highest expression. Taken together our experiments show that HA-coating of nonviral gene complexes is an interesting approach towards retinal gene therapy by intravitreal administration. To our knowledge, this is the first time electrostatic HA-coating of polyplexes with different molecular weights has been evaluated in terms of their suitability for intravitreal delivery of therapeutic nucleic acids towards the retina. [ABSTRACT FROM AUTHOR]

The synthesis of a linear beryllium bis(diazaborolyl) compound featuring the first non-cluster bond between boron and beryllium has been achieved through the reaction of Yamashita's lithium diazaborolide and BeCl2. In accord with the established chemistry of beryllium, the bonding is polar covalent in character, as determined by structural and spectroscopic analysis, as well as reactivity studies. [ABSTRACT FROM AUTHOR]

Highlights: [•] We compare two slow-release agents, Montanide ISA 51 and dextran-based microparticles. [•] CD40 agonistic antibody is delivered locally as treatment for tumors. [•] Both agents reduce side-effects of high serum levels of CD40 antibody. [•] Dextran microparticles cause inflammation associated with enhanced tumor-outgrowth. [•] Montanide ISA 51 is the preferred slow-release agent for this treatment. [ABSTRACT FROM AUTHOR]

Abstract: Cationic polymers are used as non-viral vectors for nucleic acid delivery. In this study, two biodegradable cationic polymers were evaluated for the purpose of siRNA delivery: pHPMA-MPPM (poly((2-hydroxypropyl) methacrylamide 1-methyl-2-piperidine methanol)) and TMC (O-methyl-free N,N,N-trimethylated chitosan). The silencing activity and the cellular cytotoxicity of polyplexes based on these biodegradable polymers were compared with those based on non-biodegradable pDMAEMA (poly(2-dimethylamino)ethyl methacrylate) and PEI (polyethylenimine) and with the regularly used lipidic transfection agent Lipofectamine. To promote endosomal escape, either the endosomolytic peptide diINF-7 was added to the formulations or photochemical internalization (PCI) was applied. Incubation of H1299 human lung cancer cells expressing firefly luciferase with polyplexes based on pHPMA-MPPM and TMC showed 30–40% silencing efficiency. This silencing activity was equal to or better than that obtained with the standard transfectants. Under all experimental conditions tested, the cytotoxicity of the biodegradable polymers was low. The application of PCI, as well as the addition of the diINF-7 peptide to the formulations increased their silencing activity up to 70–80%. This demonstrates that pHPMA-MPPM- and TMC-based polyplexes benefit substantially from endosomal escape enhancement. Importantly, the polyplexes retained their silencing activity in the presence of serum, and they showed low cytotoxicity. These biodegradable vectors are therefore attractive systems for further in vivo evaluations. [Copyright &y& Elsevier]

The aim of this study was to develop new hydrophilic polyesters for tissue engineering applications. In our approach, poly(benzyloxymethyl glycolide-co-ε-caprolactone)s (pBHMG-CLs) were synthesized through melt copolymerization of ε-caprolactone (CL) and benzyl-protected hydroxymethyl glycolide (BHMG). Deprotection of the polymers yielded copolymers with pendant hydroxyl groups, poly(hydroxymethylglycolide-co-ε-caprolactone) (pHMG-CL). The synthesized polymers were characterized by GPC, NMR, and DSC techniques. The resulting copolymers consisting of up to 10% of HMG monomer were semicrystalline with a melting temperature above body temperature. Water contact angle measurements of polymeric films showed that increasing HMG content resulted in higher surface hydrophilicity, as evidenced from a decrease in receding contact angle from 68° for PCL to 40° for 10% HMG-CL. Human mesenchymal stem cells showed good adherence onto pHMG-CL films as compared to the more hydrophobic PCL surfaces. The cells survived and were able to differentiate toward osteogenic lineage on pHMG-CL surfaces. This study shows that the aforementioned hydrophilic polymers are attractive candidates for the design of scaffolds for tissue engineering applications. [ABSTRACT FROM AUTHOR]

Abstract: Previous studies have shown that stereocomplexed hydrogels are rapidly formed in situ by mixing aqueous solutions of eight-arm poly(ethylene glycol)-poly(L-lactide) and poly(ethylene glycol)–poly(D-lactide) star block copolymers (denoted as PEG–(PLLA)8 and PEG–(PDLA)8, respectively). In this study, in vitro and in vivo protein release from stereocomplexed hydrogels was investigated. These hydrogels were fully degradable under physiological conditions. Proteins could be easily loaded into the stereocomplexed hydrogels by mixing protein containing aqueous solutions of PEG–(PLLA)8 and PEG–(PDLA)8 copolymers. The release of the relatively small protein lysozyme (d h =4.1 nm) followed first order kinetics and approximately 90% was released in 10 days. Bacteria lysis experiments showed that the released lysozyme had retained its activity. The relatively large protein IgG (d h =10.7 nm) could be released from stereocomplexed hydrogels with nearly zero order kinetics, wherein up to 50% was released in 16 days. The in vitro release of the therapeutic protein rhIL-2 from stereocomplexed hydrogels also showed nearly zero order kinetics, wherein up to 45% was released in 7 days. The therapeutic efficacy of stereocomplexed hydrogels loaded with 1×106 IU of rhIL-2 was studied using SL2-lymphoma bearing DBA/2 mice. The PEG–(PLLA)8/PEG–(PDLA)8/rhIL-2 mixture could be easily injected intratumorally. The released rhIL-2 was therapeutically effective as the tumor size was reduced and the cure rate was 30%, whereas no therapeutic effect was achieved when no rhIL-2 was given. However, the cure rate of rhIL-2 loaded stereocomplexed hydrogels was lower, though not statistically significant, compared to that of a single injection with 1×106 IU of free rhIL-2 at the start of the therapy (cure rate=70%). The therapeutic effect of rhIL-2 loaded stereocomplexed hydrogels was retarded for approximately 1–2 weeks compared to free rhIL-2, most likely due to a slow, constant release of rhIL-2 from the hydrogels. [Copyright &y& Elsevier]

To design stable biodegradable micelles with a size smaller than 20 nm, the self-assembly of methoxypoly(ethylene glycol)-b-oligocaprolactones (mPEG-b-OCLs), and the effect of OCL block length and terminal derivatization with an aromatic group were studied. The studied oligomers consisted of an mPEG block with a molecular weight of 750 Da and a monodisperse OCL block of 1-7 units with a hydroxyl end group that was either unmodified, benzoylated or naphthoylated. They were prepared by preparative HPLC of the polydisperse block oligomers. Differential scanning calorimetry demonstrated that the two blocks were phase separated and crystallized separately. These block oligomers formed small and almost monodisperse oligomeric micelles with a hydrodynamic diameter of 8-15 nm, which could be tailored by the size of the hydrophobic block. The critical aggregation concentration (CAC) of the unmodified mPEG-b-OCLs was 0.03-4 mg/mL, and it decreased with increasing length of the OCL chain. End group modification resulted in an extensive reduction of the CAC to values as low as 0.003 mg/mL. This is expected to result in a better stability of these oligomeric micelles toward dilution upon intravenous administration, which makes these modified mPEG-b-OCLs very promising candidates for drug delivery purposes. [ABSTRACT FROM AUTHOR]

Poly(n-butyl cyanoacrylate) microbubbles (PBCA-MB) are extensively employed for functional and molecular ultrasound (US) imaging, as well as for US-mediated drug delivery. To facilitate the use of PBCA-MB as a commercial platform for biomedical applications, it is important to systematically study and improve their stability and shelf-life. In this context, lyophilization (freeze drying) is widely used to increase shelf-life and promote product development. Here, we set out to analyze the stability of standard and rhodamine-B loaded PBCA-MB at three different temperatures (4 °C, 25 °C, and 37 °C), for a period of time of up to 20 weeks. In addition, using sucrose, glucose, polyvinylpyrrolidone (PVP), and polyethylene glycol (PEG) as cryoprotectants, we investigated if PBCA-MB can be lyophilized without affecting their size, concentration, US signal generation properties, and dye retention. Stability assessment showed that PBCA-MB remain largely intact for three and four weeks at 4 °C and 25 °C, respectively, while they disintegrate within one to two weeks at 37 °C, thereby compromising their acoustic properties. Lyophilization analyses demonstrated that PBCA-MB can be efficiently freeze-dried with 5% sucrose and 5% PVP, without changing their size, concentration, and US signal generation properties. Experiments involving rhodamine-B loaded MB indicated that significant dye leakage from the polymeric shell takes place within two to four weeks in case of non-lyophilized PBCA-MB. Lyophilization of rhodamine-loaded PBCA-MB with sucrose and PVP showed that the presence of the dye does not affect the efficiency of freeze-drying, and that the dye is efficiently retained upon MB lyophilization. These findings contribute to the development of PBCA-MB as pharmaceutical products for preclinical and clinical applications. [ABSTRACT FROM AUTHOR]